Introduction
============

Infection is a common complication that occurs in clinical trials ([@b1-etm-0-0-3239]). Since the majority of patients of the Department of Orthopedics have open wounds, there is a high risk of infection for these patients. Infections may include complicated osteomyelitis, and can be serious and even life threatening ([@b2-etm-0-0-3239]). In recent years, due to overuse and misuse of antibiotics, certain pathogen bacteria have become resistant to certain drugs. The development of antibiotic-resistant bacteria and their distribution worldwide is the result of many years of constant selection from human overuse and misuse of antibiotics ([@b2-etm-0-0-3239]). Antibiotic resistance, particularly the problems associated with superbacteria, has become a major public health issue and a global impediment for medical workers and investigators in the 21st century.

Since patients in the Department of Orthopedics are easily infected, antibacterial agents are key elements for the treatment of open wounds of patients ([@b3-etm-0-0-3239]--[@b5-etm-0-0-3239]). To analyze the distribution of drug-resistant pathogenic bacteria in infected patients and to provide a guide to ameliorate the appropriate use of antibiotics, we analyzed the distribution of drug-resistant bacteria in 126 patients at the Department of Orthopedics. Wound secretion samples were collected, the pathogen bacteria isolated and cultured, and consequently drug-resistance analyses were performed.

Patients and methods
====================

### General information

Between October 2013 and January 2015, 126 patients were selected at the Department of Orthopedics, The Fourth Affiliated Hospital of Harbin Medical University (Heilongjiang, China). There were 72 male and 48 female patients with an age range of 16--72 years and an average age of 39.4±10.2 years. Of the 126 patients, 32 cases had infectious arthritis, 48 cases had lower limb open wound infection, 18 cases had soft issue abscess, 21 cases had postoperative infection and 7 cases had other types of infection.

### Identification of bacteria and drug sensitivity test

Samples from the wound secretions and pus of patients were taken in a sterile manner and immediately sent for isolation and purification. The isolation and purification protocols were based on The National Clinical Test Regulation of Operation ([@b6-etm-0-0-3239]). For the identification of pathogen bacteria an automated microorganism identification instrument was used. The Kirby-Bauer antibiotic testing agar diffusion method was used to evaluate bacterial resistance. In this process, *Staphylococcus aureus* ATCC25923 ([Fig. 1](#f1-etm-0-0-3239){ref-type="fig"}), *Pseudomonas aeruginosa* ATCC27853, *Escherichia coli* ATCC25922 ([Fig. 2](#f2-etm-0-0-3239){ref-type="fig"}) and *Klebsiella pneumonia* ATCC700603 were used as quality control bacteria.

### Statistical analysis

Data were analyzed using SPSS 21.0 software (IBM SPSS, Armonk, NY, USA). A t-test was used to make comparisons between different groups. The size of the test was α=0.05. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Infection rate

Of the samples isolated from 126 patients, 118 samples (infection rate, 93.65%) had bacterial infections.

### Pathogen distribution

Isolated pathogens included a variety of gram-positive and -negative bacteria, with gram-negative bacteria constituting the most abundant microorganisms. In total, 47 gram-positive (39.83%) and 71 gram-negative (60.17%) bacterial strains were identified. In the gram-positive group, Staphylococcus aureus, *Staphylococcus epidermidis*, *Enterococcus sp*. and *Staphylococcus pyogenes* were identified. In the gram-negative group *Escherichia coli*, *Pseudomonas aeruginosa*, *Klebsiella pneumoni*a, and *Enterobacter cloacae* were identified. The most common bacteria were *Pseudomonas aeruginosa*, *Staphylococcus aureus*, *Escherichia coli*, *Klebsiella pneumonia* and *Staphylococcus epidermidis* ([Table I](#tI-etm-0-0-3239){ref-type="table"}).

### Drug-resistant bacteria

The results of the drug resistance tests showed that several strains were resistant to multiple antibacterial agents. Pathogens such as *Acinetobacter baumannii* were resistant to the majority of antibacterial agents used in those tests. Gram-positive bacteria were sensitive to vancomycin ([@b7-etm-0-0-3239]), while almost all of the bacteria were entirely resistant to commonly used antibiotics, such as penicillin and erythromycin. Gram-negative bacteria were sensitive to meropenem and imipenem, while almost completely resistant to sulbactam and ampicillin. We selected typical gram-positive and -negative bacteria (*Staphylococcus aureus*, *Staphylococcus epidermidis*, *Enterococcus faecalis*, *Pseudomonas aeruginosa*, *Escherichia coli*, *Klebsiella pneumonia* and *Acinetobacter baumannii*) to test their resistance to antibacterial agents ([Tables II](#tII-etm-0-0-3239){ref-type="table"} and [III](#tIII-etm-0-0-3239){ref-type="table"}).

Discussion
==========

The overuse of antibiotics has led to the emergence of several drug-resistant bacteria that render the combat against bacterial infections more difficult. The harm caused by these drug-resistant bacteria has become more severe due to the lack of appropriate antibacterial agents in our arsenal ([@b8-etm-0-0-3239]). In order to achieve a better understanding regarding the drug resistance phenomenon, we need to expand our knowledge of the proper use of antibacterial agents ([@b9-etm-0-0-3239]). We investigated the occurrence of drug-resistant bacteria in patients at the Department of Orthopedics and analyzed the distribution of pathogens and antibacterial agents. We successfully isolated bacterial pathogens from 118 patients, and identified that those patients were primarily infected with *Pseudomonas aeruginosa*, *Escherichia coli* and *Klebsiella pneumoniae*. Of the gram-positive bacteria, *Staphylococcus aureus*, *Staphylococcus epidermidis* and *Enterococcus faecalis* had the highest infection rates. These results were consistent with the existing literature ([@b10-etm-0-0-3239]). Drug sensitivity test results revealed that most gram-negative bacteria were not sensitive to sulbactam and ampicillin, but were sensitive to meropenem and imipenem. Gram-negative bacteria were resistant to penicillin and erythromycin, but sensitive to vancomycin ([@b11-etm-0-0-3239]). Drug resistance continuously increased ([@b12-etm-0-0-3239]--[@b14-etm-0-0-3239]), thus, the work of clinical workers became more cumbersome.

Results obtained from previous studies ([@b15-etm-0-0-3239]--[@b18-etm-0-0-3239]) revealed that: i) Most patients had open wounds that were easily infected; ii) external wounds caused immune disorders, thereby causing alterations in intestinal flora and leading to internal infections; iii) errors during clinical treatment, non-sterile manipulation and the failure to treat the wounds in a timely manner potentially increased the risk of infection; and iv) failure to sterilize the wound also increased the risk of infection.

Since their identification, antibiotics have been crucial agents in the battle against infectious diseases caused by bacteria. Antimicrobial therapy has been an important reason for the significant increase of average life expectancy in the 20th century ([@b19-etm-0-0-3239]). The increase of drug-resistant bacteria poses a serious threat to public health and the economy. The emergence of superbacteria has indicated that the available pool of antibacterial agents are to be appropriately used and that the appropriate antibacterial agent to which the pathogens are sensitive should be utilized ([@b19-etm-0-0-3239]). We should only consider the use of newer and more potent antibacterial agents in severe infections caused by multi-resistant bacteria.

The most effective manner in which to prevent infection is thorough correct debridement prior to surgery and timely sterilization thereafter ([@b20-etm-0-0-3239]). The use of antibiotics should be guided by patients\' etiological tests ([@b21-etm-0-0-3239]).

In conclusion, we identified that the existing risk factors in the Department of Orthopedics were complex and any non-standard procedures may cause bacterial infection. Additionally, there were evident dissimilarities among infectious bacteria with regard to their sensitivity to various antibacterial agents. Manipulation techniques during the treatment process are to be performed in a sterile manner and the use of antibacterial agents should be strictly in accordance with the results of drug sensitivity tests to provide effective etiologic information and a treatment plan for clinical trials and to reduce the risk of infection by multi-resistant bacteria.
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###### 

Isolated pathogens and their distribution.

  Pathogen classification             No. of isolated strains, strain   Composition ratio, %
  ----------------------------------- --------------------------------- ----------------------
  Gram-positive bacteria                47                              39.83
      *Staphylococcus aureus*           16                              13.56
      *Staphylococcus epidermidis*      12                              10.16
      *Enterococcus faecalis*           10                              8.47
      *Staphylococcus purulent*           6                             5.08
      *Staphylococcus haemolyticus*       4                             3.39
  Gram-negative bacteria                71                              60.17
      *Pseudomonas aeruginosa*          20                              16.95
      *Escherichia coli*                15                              12.71
  Klebsiella pneumonia                  12                              10.17
      *Acinetobacter baumannii*         10                              8.47
      *Bacillus aerogenes*                5                             4.24
      *Enterobacter cloacae*              4                             3.39
    Others                                5                             4.24
  Total                               118                               100.0

###### 

Drug-resistance test results for gram-positive bacteria \[n (%)\].

  Antibacterial agents          *Staphylococcus aureus* 16   *Staphylococcus epidermidis* 12   *Enterococcus faecalis* 10
  ----------------------------- ---------------------------- --------------------------------- ----------------------------
  Penicillin, n (%)             14 (87.5)                    9 (75)                            8 (80)
  Erythromycin, n (%)           15 (93.75)                   10 (83.33)                        9 (90)
  Gentamicin, n (%)             4 (25)                       8 (66.67)                         7 (70)
  Rifampicin, n (%)             6 (37.5)                     7 (58.33)                         4 (40)
  Levofloxacin, n (%)           9 (56.25)                    7 (58.33)                         5 (50)
  Ciprofloxacin, n (%)          6 (37.5)                     7 (58.33)                         3 (30)
  Ampicillin/sulbactam, n (%)   10 (62.5)                    8 (66.67)                         4 (40)
  Amoxicillin, n (%)            3 (18.75)                    8 (66.67)                         4 (40)
  Cefazolin, n (%)              4 (25)                       9 (75)                            5 (50)
  Ceftriaxone, n (%)            3 (18.75)                    8 (66.67)                         4 (40)
  Vancomycin, n (%)             0                            0                                 0

###### 

Drug-resistance test results for gram-negative bacteria \[n (%)\].

  Antibacterial agents   *Pseudomonas aeruginosa*   *Escherichia coli*   *klebsiella pneumonia*   *Acinetobacter baumannii*
  ---------------------- -------------------------- -------------------- ------------------------ ---------------------------
  Sulbactam, n (%)       18 (90)                    9 (60)               8(66.67)                 8 (80)
  Ampicillin, n (%)      19 (95)                    10 (66.67)           9 (75)                   9 (90)
  Gentamicin, n (%)      7 (35)                     8 (53.33)            7 (58.33)                4 (40)
  Ceftazidime, n (%)     9 (45)                     7 (46.67)            4 (33.33)                4 (40)
  Cefepime, n (%)        12 (60)                    7 (46.67)            5 (41.67)                2 (20)
  Ceftriaxone, n (%)     9 (45)                     7 (46.67)            3 (25)                   3 (30)
  Cefazolin, n (%)       13 (65)                    8 (53.33)            4 (33.33)                2 (20)
  Ciprofloxacin, n (%)   6 (30)                     8 (53.33)            4 (33.33)                5 (50)
  Norfloxacin, n (%)     7 (35)                     9 (60)               5 (41.67)                4 (40)
  Levofloxacin, n (%)    6 (30)                     8 (53.33)            4 (33.33)                4 (40)
  Meropenem, n (%)       1 (5)                      0                    0                        0
  Imipenem               0                          0                    0                        0
